Search
for
Sort by
Research 751–780 of 1000+
- Care of the newborn with ichthyosis
- Skin signs in anorexia nervosa
- Gefitinib: an adverse effects profile
- Hair Shaft Abnormalities – Clues to Diagnosis and Treatment
- Relative changes in the pattern of diseases presenting in dermatology outpatient clinic in the era of the COVID ‐19 pandemic
- Advances in the Management of Cutaneous Toxicities of Targeted Therapies
- Keratosis follicularis spinulosa decalvans: a family study of seven male cases and six female carriers.
- Semiology of skin toxicity associated with epidermal growth factor receptor (EGFR) inhibitors
- Treatment of hirsutism by finasteride and flutamide in women with polycystic ovary syndrome
- Periorbital facial rejuvenation; applied anatomy and pre-operative assessment
- Seventeen Cases of Alopecia Areata: Combination of SADBE Topical Immunotherapy with Other Therapies
- Ocular Effects of Cosmetic Products and Procedures
- The red face: Rosacea
- Lichen planus and other cutaneous manifestations in chronic hepatitis C: pre- and post-interferon-based treatment prevalence vary in a cohort of patients from low hepatitis C virus endemic area
- Molecular characterization of xerosis cutis: A systematic review
- Severe Physical Complications among Survivors of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis
- The management of EGFR inhibitor adverse events: a case series and treatment paradigm
- Cutaneous Lesions in Systemic Lupus Erythematosus
- The skin landscape in diabetes mellitus. Focus on dermocosmetic management
- Demodex
- Non-Rash Skin Toxicities Associated with Novel Targeted Therapies
- Skin Disease Among Latino Farmworkers in North Carolina
- Changes in dermatological complaints among healthcare professionals during the COVID-19 outbreak in Turkey
- Skin disorders in elderly subjects
- Dermatologic adverse events in pediatric patients receiving targeted anticancer therapies: A pooled analysis
- Menopause, skin and common dermatoses. Part 2: skin disorders
- Adverse cutaneous reactions to the new second-generation tyrosine kinase inhibitors (dasatinib, nilotinib) in chronic myeloid leukemia
- Thyroid hormone action on skin.
- Arabic version of Skindex‐16: Translation and cultural adaptation, with assessment of reliability and validity
- THE PREVALENCE OF SKIN DISEASE IN THE GERIATRIC AGE GROUP